Amarin Corporation plc (AMRN) Buy Target $9.65 Sell Target $13.18

Trade Setup

Buy Target $9.65
Sell Target $13.18

Amarin Corporation plc, a pharmaceutical company, develops and commercializes therapeutics for the treatment of cardiovascular diseases in the United States. The company’s lead product is Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. 

 
Trending Ideas

Featured Stocks On The Move

Featured Stocks On The Move